AFP and hepatocellular carcinoma: As a diagnostic tool for HCC, AFP level is determined by immunoenzymatic chemiluminescence; the cutoff of serum AFP levels for significant prognostic impact for HCC is 20 ng/mL (AFP-negative: <20 ng/mL and AFP-positive: ≥20 ng/mL) [22].